Myasthenia gravis: How to treat?

Acta Myologica

Volumn 23, Issue 3, 2004, Pages 140-145

  Tireli, H ^a   Karlikaya, Geysu ^a   Tutkavul, K ^a   Akpinar, A ^a   Okay, T ^b  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Myasthenia gravis; Thymectomy; Treatment

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOPATHY; NEUROMUSCULAR TRANSMISSION; PALLIATIVE THERAPY; PLASMAPHERESIS; RETROSPECTIVE STUDY; SERODIAGNOSIS; STOMACH DISEASE; THYMECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYMECTOMY; TREATMENT OUTCOME;

EID: 17444388939     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Younger DS, Worall BB, Penn AS. Myasthenia Gravis: Historical Perspective and Overview. Neurology 1997;45:1-7.
2. Keesey JC. Clinical evaluation and management of Myasthenia Gravis. Muscle & Nerve, 2004;29:484-505.
3. Gronseth Gs, Barohn RJ. Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000;55:7-15.
4. Pruitt JN, Swift TR. Therapies for Disorders of the Neuromuscular Junction. Arch. Neurol. 2002;59:739-42.
5. Christensen PB, Jensen TS, Tsiropoulus I, Serensen T. Mortality and survival in myasthenia gravis: a Danish population based study. J Neurol Neurosurg Psychiatry 1998;64:78-83.
6. Osserman KE, Genkins G. Studies in Myasthenia Gravis: Review of a twenty years experience in over 1200 patients. Mt Sinai J Med 1972;38:497-535.
7. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 2000;48:1442-8.
8. Heckmann JM, LeePan EB, Eastman RW. High-dose immunosuppressive therapy in generalised myasthenia gravis a 2-year follow-up study. S Afr Med J 2001;91:765-70.
9. Gajdos P, Elkarrat D, Chevret S. A randomized clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J Neurol Neurosurg Psychiatry 1993;56:1157-63.
10. Palace J, Newsom-Davis J, Lecky B, et al. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998;50:1778-83.
11. Romi F, Gilhus NE, Aarli JA. Thymectomy and muscle antibodies in myasthenia gravis. Tidsskr Nor Laegeforen 2004;124:629-31.
12. Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann NY Acad Sci 2003;998:413-23.
13. Schulze W, Laczkovics A, Richter J, et al. Thymectomy in myasthenia gravis: an analysis of current status. Chirurgie 1998;69:1345-51.
14. Cosi V, Romani A, Lombardi M, Raiola E, et al. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J Neurol 1997;244:548-55.
15. Beghi E, Antozzi C, Batocchi AP, Cornelio F, et al. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 1991;106:213-20.
16. Mantegazza R, Beghi E, Pareyson D, Antozzi C, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990;237:339-44.
17. Donaldson DH, Ansher M, Horan S, et al. The relationship of age to outcome in myasthenia gravis. Neurology 1990;40:786-90.
18. Tellez-Zentono JF, Remes-Troche JM, Garcia-Ramos G, et al. Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. Eur Neurol 2001;46:171-7.
19. El-Medany Y, Hajjar W, Essa M, et al. Predictors of outcome for myasthenia gravis after thymectomy. Asian Cardiovasc Thorac Ann 2003;11:323-7
20. Dural K, Yildirim E, Han S, et al. The importance of the time interval between diagnosis and operation in myasthenia gravis patients. J Cardiovasc Surg 2003;44:125-9.
21. Özdemir N, Kara M, Dikmen E, et al. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 2003;23:233-7.
22. Remes-Troche JM, Tellez-Zentono JF, Estanol B, Garduno-Espinoza J. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res 2002;33:545-51.
23. Singh RS, Behera SK, Saji R, Dhaliwal RS. Thymectomy for myasthenia gravis: 12-year experience. Asian Cardiovasc Thorac Ann 2003;11:299-303.
24. Tansel T, Onursal E, Barlas S, Tireli E. Results of surgical treatment for nonthymomatous myasthenia gravis. Surg Today 2003;33:666-70.
25. Al-Mahdawi Am, Al Talib NM. Outcome of thymectomy in patients with Myasthenia Gravis. Saudi Med J 2002;23:39-43.